Book a Meeting

NGA2 Glycan (A2, G0), 2-AA Labelled [Labeled Glycan Standards] (CAT#: CB-P369-K) Datasheet

Product Type
Glycan Standards
Asialo-, agalacto-, bi-antennary complex-type N-glycan (oligosaccharide). NGA2 is the agalacto- substructure of NA2 glycan.
Synonyms: NGA2 N-linked oligosaccharide.
Sources: NGA2 glycan is found on many mammalian glycoproteins including human IgG and is a substructure of bi-antennary N-linked oligosaccharides such as A2, A1, and NA2 which are widely found on glycoproteins. This product is typically purified from the oligosaccharide pool released from bovine serum by hydrazinolysis using a combination of HPLC and glycosidase digestion.
Form: Dry. Dried by centrifugal evaporation from an aqueous solution.
Molecular Weight: 1317
Purity:> 90% pure as assessed by a combination of 1 H-NMR and HPLC.
Glycoproteins and glycopeptides containing N-linked glycans
Handling Advice
Allow the unopened vial to reach ambient temperature and tap unopened on a solid surface to ensure that most of the lyophilized material is at the bottom of the vial. Gently remove the cap, add the desired volume of reconstitution medium, re-cap and mix thoroughly to bring all the oligosaccharide into solution. For maximal recovery of oligosaccharide, ensure that the cap lining is also rinsed and centrifuge the reconstituted vial briefly before use. Ensure that any glass, plasticware or solvents used are free of glycosidases and environmental carbohydrates.
Refridgerate (-20°C) both before and after dissolution. This product is stable for at least 5 years as supplied.
Shelf Life
Stability: Stable at least 12 months when stored properly. Several days exposure to ambient tempertures will not reduce activity.
Research Use
For research use only. Not for human or drug use

Figure 1 Structure

Figure 2 500 MHz 1H-NMR of NGA2 Glycan

Figure 3 500 MHz 1H-NMR of NGA2 Glycan

All products and services are for Research Use Only. Do Not use in humans.


Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *